Active ingredientAfamelanotideCat. No. P-A048-001CAS 75921-69-6Family · Pharmaceutical analytical standards
Afamelanotide
A synthetic peptide analogue of the hormone alpha-MSH, which stimulates melanin production in the skin; synthesised in the 1980s at the University of Arizona, it is used as a subcutaneous implant in erythropoietic protoporphyria and has been approved in the United States since 2019. This family brings together the active ingredient.
Did you know?Its first approval anywhere came from Italy: in 2010 the Italian medicines agency AIFA authorised it for erythropoietic protoporphyria, before the European Union and the United States. It was originally called melanotan-I.
Go to the active ingredient →Active ingredientAfamelanotideCat. No. P-A048-001CAS 75921-69-6No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.